MedPath
HSA Approval

DEXCOPHAN PAEDIATRIC LINCTUS 5.5 mg/5 ml

SIN03252P

DEXCOPHAN PAEDIATRIC LINCTUS 5.5 mg/5 ml

DEXCOPHAN PAEDIATRIC LINCTUS 5.5 mg/5 ml

June 2, 1989

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

ELIXIR

ORAL

Medical Information

R05DA09

dextromethorphan

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

Active Ingredients

DEXTROMETHORPHAN HBr

5.5 mg/5 ml

Dextromethorphan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXCOPHAN PAEDIATRIC LINCTUS 5.5 mg/5 ml - HSA Approval | MedPath